Cell and Gene Therapy Insights

Industry 4.0: a vision for personalized medicine supply chains?

Juergen Branke, Suzanne S. Farid, Nilay Shah · 2016 · 64 citations · Full text

Pharmacy, Biotechnology, Supply Chain Management +17

Downstream bioprocessing of AAV vectors: industrial challenges & regulatory requirements

Matthias Hebben · 2018 · 39 citations

Life Sciences, Bioengineering, Biotechnology +17

AAV vector production: state of the art developments and remaining challenges

Otto‐Wilhelm Merten · 2016 · 38 citations

Life Sciences, Biotechnology, Molecular Biology +14

Vascular microphysiological systems to model diseases

Qiao Zhang, Xu Zhang, George A. Truskey · 2020 · 34 citations · Full text

Life Sciences, Bioengineering, Cell Biology +17

Non-Viral Vector Mediated Gene Delivery: the Outsider to Watch Out For in Gene Therapy

Alengo Nyamay’Antu, Maxime Dumont, Valérie Kedinger et al. · 2019 · 34 citations · Full text

Pharmacy, Biotechnology, Pharmaceutical Biotechnology +14